Use of certain imidazol carbazols in treating stress-related manic-depressive disorders
US5561149A · kind A · utility
90Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 1995 |
| Grant date | Oct 1, 1996 |
| Priority date | — |
| Expiry date | Mar 14, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Use of a mono or bicyclic carbocyclic, or heterocyclic carboxylic, acid ester or amide or an imidazolyl carbazol in the manufaccure of a medicament suitable for the treatment of stress-related psychiatric disorders, for increasing vigilance, for the treatment of rhinitis or serotonin-induced disorders and/or coadministration with another active agent to increase the bioavailability thereof, or for nasal administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.